<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">335171</id>
  <title nil="true"/>
  <common-name>2-[[5-(4-bromophenyl)-4-(2-methylprop-2-enyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-phenylprop-2-enylidene]amino]acetamide</common-name>
  <description>2-[[5-(4-bromophenyl)-4-(2-methylprop-2-enyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-phenylprop-2-enylidene]amino]acetamide is a chemical compound with the formula C23H22BrN5OS. It has an average molecular weight of 496.40 g/mol.</description>
  <cas>330838-49-8</cas>
  <pubchem-id>9657064</pubchem-id>
  <chemical-formula>C23H22BrN5OS</chemical-formula>
  <weight>496.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T17:13:02Z</created-at>
  <updated-at type="dateTime">2026-08-30T17:13:02Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=C)CN1C(=NN=C1SCC(=O)NN=CC=CC2=CC=CC=C2)C3=CC=C(C=C3)Br</moldb-smiles>
  <moldb-formula>C23H22BrN5OS</moldb-formula>
  <moldb-inchi>InChI=1S/C23H22BrN5OS/c1-17(2)15-29-22(19-10-12-20(24)13-11-19)27-28-23(29)31-16-21(30)26-25-14-6-9-18-7-4-3-5-8-18/h3-14H,1,15-16H2,2H3,(H,26,30)/b9-6+,25-14+</moldb-inchi>
  <moldb-inchikey>VUPKSIPRNIXBRW-HQUXDSKKSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">495.07284</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM331064</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[5-(4-bromophenyl)-4-(2-methylprop-2-enyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-phenylprop-2-enylidene]amino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0285646</sync-id>
  <structure-inchikey>VUPKSIPRNIXBRW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000000000800000000800000000000000000000000000000000000000000000000002000004000000002084004000000080000000000000200000000000000000000000000000000000000020000000000200000004808010000000000000210000001000000000020000800400800100000000002000000000420000000040000000800000000000000184880000000101000000000000000000000000008000000000400200080000000000000000400000000000102800400000000000004000000000000100004000000000000000002000000200000000000000000000800004001048000000000400000000010000000000000000044000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAfAAAAIQAAAIABBgBgAAAAAQMGACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:36:53Z</structure-indexed-at>
</compound>
